{
  "meta": {
    "title": "Macular degeneration",
    "url": "https://brainandscalpel.vercel.app/macular-degeneration-612415af-dd8e86.html",
    "scrapedAt": "2025-12-01T05:12:36.338Z",
    "type": "article"
  },
  "content": "\n                <div><h1>Introduction</h1>\n<p>Age-related macular degeneration (AMD) is a major cause of blindness and visual impairment in older adults (age &gt;50).&nbsp; It involves the <strong>progressive loss of central vision</strong> due to degenerative changes in the macula, the central part of the retina responsible for high acuity, fine detail, and central vision.&nbsp; AMD is classified into dry (atrophic) and wet (neovascular) subtypes.&nbsp; The dry form typically affects both eyes and has an insidious onset.&nbsp; By contrast, the wet form is associated with a more rapid and aggressive course that requires prompt treatment.</p>\n<h1>Risk factors</h1><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Age &gt;50</li>\n\t<li>Smoking (most significant modifiable risk factor)</li>\n\t<li>Genetic predisposition/family history</li>\n\t<li>Low dietary intake of antioxidants (eg, fruits, vegetables)</li>\n</ul>\n<h1>Anatomy</h1><br><br><p>The macula is the portion of the retina responsible for central vision.&nbsp; In the macula, each cone synapses to a single bipolar cell that synapses to a single ganglion cell (in contrast to the peripheral retina, where multiple cones converge onto a single ganglion cell).&nbsp; Because of this arrangement, visual acuity (sharpness, contrast) and metabolic activity are greater in the macula than in any other area of the retina.</p>\n<h1>Pathogenesis</h1><br><br><p>AMD is a complex and multifactorial condition that involves degeneration of the retinal photoreceptors of the macula.&nbsp; It is separated into dry (most common) and wet subtypes, which are differentiated by their pathogenesis (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L27250.jpg\" alt=\"figure 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 1</div>\n                                </div>\n                                ).<p></p>\n<h2>Dry (atrophic) AMD </h2><br><br><p>Chronic oxidative injury, which occurs with normal aging (and is exacerbated by smoking), preferentially damages the retinal pigment epithelium (RPE), the outermost layer of the retina that transports nutrients from the choroid to the photoreceptors and metabolizes retinal waste products.&nbsp; RPE damage/dysfunction causes lipid and protein waste (ie, drusen) to build up between the retina and the choroid.&nbsp; These drusen deposits create chronic inflammation and limit nutrient delivery to the retina, leading to death of the overlying photoreceptors.&nbsp; The metabolically active macula is preferentially affected, thereby resulting in <strong>gradual reduction</strong> in central visual acuity.</p>\n<h2>Wet (neovascular) AMD</h2><br><br><p>Progressive waste product accumulation (eg, drusen deposits) can eventually result in retinal hypoxia, which stimulates local vascular endothelial growth factor (VEGF) production.&nbsp; VEGF causes <strong>neovascularization</strong> (ie, formation of new, abnormal blood vessels) underneath the retina, and also increases vascular permeability, making these new vessels prone to leakage.&nbsp; Subretinal fluid/hemorrhage disrupts photoreceptor function and eventually creates fibrosis/atrophy of the macula; it also increases the risk of retinal detachment.&nbsp; Vision loss in wet AMD is typically <strong>severe</strong> and <strong>rapidly progressive</strong> (within days to weeks).</p>\n<h1>Clinical presentation</h1><br><br><p>Although patients may initially be asymptomatic, the clinical manifestations of macular damage include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Painless loss of fine, central visual acuity</strong>:&nbsp; blurry vision and difficulties with contrast sensitivity (eg, reading), dark adaptation (eg, night driving), and facial recognition.&nbsp; Peripheral vision is typically unaffected.</li>\n\t<li><strong>Metamorphopsia</strong> (distorted vision):&nbsp; straight lines appear wavy because visualization of straight lines requires fine visual acuity that primarily involves the macula.\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>Amsler grid test (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L68591.png\" alt=\"figure 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 2</div>\n                                </div>\n                                ), a square grid of straight vertical and horizontal lines with a central dot, is used as a screening tool.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Central scotomas</strong> (blind spots) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L18063.png\" alt=\"figure 3\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 3</div>\n                                </div>\n                                )</li>\n</ul><br><br><p>Clinical factors that differentiate dry AMD and wet AMD:</p>\n<h2>Dry AMD</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Both eyes</strong> are usually involved and progression is gradual (over years).</li>\n\t<li>Increasing difficulty reading and driving at night is common.</li>\n\t<li>Dilated fundoscopic examination reveals <strong>subretinal yellow-white drusen</strong> deposits and evidence of retinal atrophy clustered around the macula (late finding) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L104182.png\" alt=\"image 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 1</div>\n                                </div>\n                                ).</li>\n</ul>\n<h2>Wet AMD</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Onset of symptoms is rapid (over days to weeks) and often <strong>affects one eye</strong> (but can be bilateral).</li>\n\t<li>Metamorphopsia occurs more commonly in wet AMD due to the effects of subretinal hemorrhage and fluid accumulation beneath the retina.</li>\n\t<li>Dilated fundoscopic examination reveals <strong>neovascularization</strong> with intraretinal or subretinal fluid accumulation and/or <strong>hemorrhages</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L11896.png\" alt=\"image 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 2</div>\n                                </div>\n                                ), and grayish-green subretinal discoloration at the macula.</li>\n</ul><br><br><p>Dry AMD can progress to wet AMD.&nbsp; A sudden decrease in visual acuity in a patient with dry AMD should prompt urgent evaluation for wet AMD.</p>\n<h1>Differential diagnosis</h1><br><br><p>The differential diagnosis of AMD includes:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Open-angle glaucoma</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L17295.jpg\" alt=\"image 3\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 3</div>\n                                </div>\n                                ):&nbsp; leads to progressive, painless loss of peripheral rather than central vision.&nbsp; Examination shows optic nerve atrophy with increased optic cup size and cup-to-disc ratio.</li>\n\t<li><strong>Diabetic retinopathy</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L93955.jpg\" alt=\"image 4\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 4</div>\n                                </div>\n                                ):&nbsp; causes insidious vision loss and is characterized by retinal neovascularization and hemorrhages.&nbsp; However, hyperglycemia-induced microvascular damage usually affects the entire retina, in contrast to the preferential damage to the macula in AMD.</li>\n\t<li><strong>Hypertensive retinopathy</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L11953.jpg\" alt=\"image 5\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 5</div>\n                                </div>\n                                ):&nbsp; can present with gradual, painless binocular vision loss.&nbsp; Funduscopic examination may reveal hard exudates, which may look similar to drusen.&nbsp; However, classic findings also include the copper wiring appearance of retinal arterioles as well as arteriovenous nicking, flame-shaped hemorrhages, and papilledema.</li>\n\t<li><strong>Retinal vein occlusion</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L104861.png\" alt=\"image 6\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 6</div>\n                                </div>\n                                ):&nbsp; presents with acute onset (hours to weeks) of painless, monocular vision loss but can be distinguished by its characteristic fundoscopic findings, including retinal hemorrhages, macular edema, and dilated, tortuous veins.</li>\n\t<li><strong>Central retinal artery occlusion</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L11893.png\" alt=\"image 7\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 7</div>\n                                </div>\n                                ):&nbsp; involves development of sudden-onset, painless monocular loss of vision with a cherry-red macula and retinal pallor on fundoscopy.</li>\n\t<li><strong>Retinal detachment</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L17992.png\" alt=\"image 8\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 8</div>\n                                </div>\n                                ):&nbsp; also presents with acute, painless, monocular vision loss.&nbsp; However, patients often see flashes of light (photopsia), floaters, or webs, which are not features of macular degeneration.&nbsp; Retinal detachment usually begins in the periphery, causing a peripheral visual field defect that progresses toward the center.</li>\n</ul>\n<h1>Diagnosis</h1><br><br><p>Diagnosis of AMD is primarily clinical based on history and physical examination.</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Progressive visual changes such as difficulty reading or driving at night, trouble adapting to dark environments, or gradual development of a central scotoma suggest dry AMD.&nbsp; Dilated fundoscopy that reveals drusen deposits and macular atrophy confirms the diagnosis.</li>\n\t<li>Acute onset of metamorphopsia and significant central vision loss is consistent with wet AMD.&nbsp; Neovascularization and subretinal fluid/hemorrhage are confirmatory findings on dilated fundoscopic examination.</li>\n</ul><br><br><p>Imaging studies (eg, optical coherence tomography) that provide detailed images of the retina may help gauge the stage/severity of AMD and evaluate for subtle signs of wet AMD that may be missed on fundoscopy.</p>\n<h1>Imaging studies</h1><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Optical coherence tomography (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L101096.png\" alt=\"image 9\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 9</div>\n                                </div>\n                                ):&nbsp; provides high-resolution, cross-sectional images of the retina, allowing detailed assessment of retinal layers.&nbsp; It can identify drusen deposits, RPE thinning/atrophy, subretinal fluid, and neovascularization.</li>\n\t<li>Fluorescein angiography:&nbsp; used to detect neovascularization in wet AMD and highlight areas of leakage.</li>\n</ul>\n<h1>Management</h1><br><br><p>There are currently no available treatments to halt or reverse retinal damage from dry AMD, though the following interventions may delay onset or slow progression:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Smoking cessation</strong></li>\n\t<li>Antioxidant-rich diet:&nbsp; green leafy vegetables and fish (eg, Mediterranean diet), which may decrease the risk of developing advanced AMD</li>\n\t<li>Nutritional supplements (eg, vitamins C and E, zinc, copper, lutein), which may help slow progression in intermediate AMD or advanced AMD in one eye, though evidence is limited</li>\n</ul><br><br><p>Wet AMD requires urgent intervention once identified as treatment improves visual outcomes.&nbsp; The mainstay of treatment is <strong>anti-VEGF therapy</strong>.&nbsp; In this treatment, intravitreal injections of anti-VEGF agents (eg, ranibizumab, bevacizumab) inhibit the growth of abnormal blood vessels and reduce vascular leakage, improving or stabilizing vision.&nbsp; Laser photocoagulation is another treatment for neovascularization in wet AMD.&nbsp; However, it is used less frequently because anti-VEGF therapy is so effective.</p>\n<h1>Prognosis</h1><br><br><p>The prognosis of AMD depends on the type and stage of the disease:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Dry AMD:&nbsp; vision loss is typically gradual and less severe than wet AMD.&nbsp; However, disease progression results in irreversible visual impairment.</li>\n\t<li>Wet AMD:&nbsp; without treatment, wet AMD can lead to rapid and severe central vision loss.&nbsp; With anti-VEGF therapy, many patients experience stabilization or improvement in vision, but regular treatment is often necessary.</li>\n</ul>\n<h1>Prevention</h1><br><br><p>Smoking is the leading modifiable risk factor for AMD.&nbsp; Maintaining a healthy diet rich in vitamins and antioxidants may also provide some protective benefits.</p>\n<h1>Summary</h1><br><br><p>Macular degeneration is a leading cause of vision loss, particularly in older adults (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/101551.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 1\n                                    </a>\n                                </div>\n                                ).&nbsp; Injury to photoreceptors in the macula leads to progressive central vision loss.&nbsp; Dry AMD is the most common subtype and occurs due to the deposition of drusen beneath the retinal pigment epithelium.&nbsp; Although it progresses slowly over years, there is no effective treatment at this time.&nbsp; Wet AMD causes rapid vision loss due to neovascularization and subretinal fluid accumulation from VEGF production.&nbsp; Treatment with intravitreal anti-VEGF injections improves visual outcomes.<p></p>\n</div>\n\n            "
}